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Transformation of Undifferentiated Thy-1 B220+ Thymic
Lymphoid Cells by the Abelson Murine
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Intrathymic injection of the Abelson murine leukemia virus (A-MuLV) results in transforma-
tion of immature T and B lymphoid cells. In this report we demonstrate that the concentration
of A-MuLV injected into murine thymi influences the selection of the transformation target.
Thus, concentrated A-MuLV gives rise to Thy-1+ B220- thymomas. In contrast, dilute virus
induces B220+ thymomas that also express low levels of Thy- (Thy-11), a phenotype that is
similar to marrow-derived progenitor B-lymphoid cells (pro-B cells) that are highly suscepti-
ble to A-MuLV transformation in vitro. However, rare B220+ lymphoid cells isolated from
normal adult thymi were not transformed by A-MuLV in vitro, while B220+ cells isolated
from bone marrow were highly susceptible to transformation by A-MuLV. The Thy-11
B220+popt]lation in the primary thymomas had not rearranged TCRT, TCR3, or Igc genes, but
contained subpopulations that assembled Ig DJH or VDJH genes and were therefore similar to
transformed pro- and pre-B cells obtained from A-MuLV infected fetal liver and adult bone
marrow, respectively. However, unlike A-MuLV-transformed pro- and pre-B cells, many (40-
70%) of the Thy-1 B220+ transformed thymoma cells had not rearranged Igh genes, and
therefore appear to represent undifferentiated lymphoid cells. We conclude that A-MuLV may
transform an undifferentiated lymphoid target in the thymus.
Keywords: Abelson Murine Leukemia Virus, A-MuLV, lymphocyte progenitor, Ig genes, T cell receptor
genes, thymic lymphoma
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INTRODUCTION
The ability of the v-abl oncogene of the Abelson
murine leukemia virus (A-MuLV) to immortalize
immature lymphoid cells from bone marrow and fetal
liver has been useful for identifying and characteriz-
ing immature stages of B-cell development (Rosen-
berg and Witte, 1988; Alt et al., 1984). Depending on
the extent of Igh rearrangement, most transformed
cell lines derived from A-MuLV infected bone mar-
row or fetal liver can be divided into one of three cat-
egories. Cell lines in the most common category
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represent transformed pre-B cells that exhibit com-
plete variable region formation on at least one allele.
However, because of the imprecision of VHDJH
recombination, these transformants may or may not
express cytoplasmic mu chains (Cg) (Alt et al., 1984).
Even if a functional Igh variable region is formed and
Ct is expressed, these pre-B cell transformants are
usually arrested at this stage of B-cell differentiation
by v-abl suppression of RAG gene expression and/or
inhibition of NF-KB/rel-mediated intron enhancer
activity (Chen et al., 1994; Klug et al., 1994).
A second marrow-derived A-MuLV-transformed
cell type is arrested at the DJH stage of maturation.
These cells fail to rearrange VH to DJH and are
referred to as DJ-fixed (DJ-f) (Ramakrishnan and
Rosenberg, 1988; Wang and Rosenberg, 1993).
A-MuLV transformed cell lines derived from fetal
liver also have rearranged only DJH segments, but
unlike the DJ-f population obtained from marrow, are
not blocked at this stage of development and continue
assembling Igh genes so that _<10% of the cells
express Cg. This third type of A-MuLV transformant
is referred to as DJ-rearranging (DJ-r) (Ramakrishnan
and Rosenberg, 1988).
Thymic lymphocytes can also be transformed by
A-MuLV (Clark et al., 1993; Cook, 1982; Cook,
1985; Cook and Balaton, 1987; Holland et al., 1991;
Kimoto et al., 1989; Risser et al., 1985; Scott et al.,
1986; D’Andrea et al., 1987), and these can be divided
into three categories based on their level of Thy-1
expression (Clark et al., 1993; Cook, 1982; Cook,
1985; Cook and Balaton, 1987; Scott et al., 1986).
Transformed thymocytes that express high levels of
Thy-1 (Thy-1hi) are also B220- and have rearranged
their TCR/ and 3 genes. These represent early-to-inter-
mediate stages of ?/6 or t/ T-cell development
(Clark et al., 1993; Cook, 1982; Cook, 1985; Cook
and Balaton, 1987; Holland et al., 1991; Risser et al.,
1985; Scott et al., 1986). Other A-MuLV transformed
thymic lymphocytes do not express Thy-1 (Cook,
1982; Cook, 1985; Cook and Balaton, 1987; Kimoto
et al., 1989; Risser et al., 1985; Scott et al., 1986;
D’Andrea et al., 1987), and when examined, express
B220 (Kimoto et al., 1989; Risser et al., 1985; Scott et
al., 1986). These have extensively rearranged Igh
genes and often have rearranged Ig and TCR7 genes,
but maintain unrearranged TCRI3 genes (Cook and
Balaton, 1987; Kimoto et al., 1989; Scott et al., 1986;
D’Andrea et al., 1987). Therefore, this A-MuLV-trans-
formed thymocyte population consists of pre-B cells,
similar to the common marrow-derived A-MuLV
transformant. Thus, rare B-progenitor cells that can
be transformed by A-MuLV appear to exist in the
thymi of adult mice. The origin of these cells and their
relationship to marrow-derived B-progenitor cells are
not understood at this time.
Also of interest are the relatively rare A-MuLV-
induced thymoma-derived cell lines reported to
express low levels of Thy-1 (Thy-ll)(Cook, 1982;
Cook, 1985; Cook and Balaton, 1987; Holland et al.,
1991) because in murine hematolymphoid popula-
tions, Thy-11 often characterizes progenitor and stem
cells (Kondo et al., 1997; Lian et al., 1997; McKenna
and Morrissey 1998; Morrison and Weissman 1994;
Miiller-Sieburg et al., 1986; Soloffet al. 1997). In
addition, Thy-11 is also found expressed on early thy-
mic progenitors (Antica et al. 1994; Carlyle et al.
1997; Hattori et al? 1994; Kawamoto et al. 1999; Wu
et al. 1991). Unlike the other categories of
A-MuLV-transformed thymoma cells that clearly rep-
resent distinct stages of T or B-cell development, the
few A-MuLV-transformed Thy-11 cell lines that have
been examined express an ambiguous phenotype that
cannot unequivocally be assigned to a particular stage
of T or B lymphocyte development (Cook, 1985;
1987; Cook and Balaton, 1987; Risser et al., 1985;
D’Andrea et al., 1987; Holland et al., 1991). These
thymoma cells may be analogous to cases of acute
human leukemia in which malignant lymphoblasts
with an ambiguous phenotype are thought to arise
from the transformation of a transitory lymphoid pro-
genitor poised at the juncture of commitment to either
the T or B-lymphoid lineage (Paietta, 1992; Greaves,
1986). Since progenitor populations capable of giving
rise to both T and B-cells can be found in the thymi of
adult and fetal mice (Akashi et al. 1998; Hattori et al.
1994; Matsuzaki et al., 1993; Peault et al. 1994; Wu et
al., 1991), it is feasible that primitive lymphoid pro-
genitor cells not fully committed to either lymphoid
lineage may be targets for A-MuLV transformation in
the thymus.LYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 3
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FIGURE Coexpression of B220 and Thy-11 cells on immature lymphocytes in primary thymomas induced by A-MuLV. Three representa-
tive thymomas in which 35%, 67% and 80% of the cells were B220 were analyzed for coexpression of B220 and Thy-1 by two color flow
cytometry as described in the Materials and Methods. The data show that the B220 cells expressed low levels of Thy- 1, and that B220- cells
were Thy-1 hi. This is representative of 22 thymic tumors analyzed. B220 cells were also sorted to >95% purity over the anti-B220 magnetic
column then stained with (solid histograms) FITC-R6-60.2 (anti-IgM), FITC-S7 (anti-CD43), PE-53-7.3 (anti-CD5), PE-RM2-5
(anti-CD2), or PE-M1/69 (anti-HSA) (data not shown) and analyzed by flow cytofluorometry. Isotype-matched irrelevant antibodies were
used to establish background fluorescence (open histograms). These data are representative of nine Thy-11 B220 tumor populations that
were examined. Staining profiles for normal thymus and electronically gated apleen and bone marrow B220 cells are included for control.4 ERIC Y. CHEN et al.
While comparing thymomas induced by intrathy-
mic injection of different retroviruses, we noticed that
distinct Thy-ll and Thy-lhi populations often
co-existed in the same primary tumor that was
induced with either the v-abl or BCR-ABL oncogenes.
In contrast, we only observed Thy-lhi cells in tumors
induced with the Moloney murine leukemia virus
(Clark et al., 1993). The Thy-11 tumor cells could
represent the in vivo counterpart of the rare Thy-11
A-MuLV transformed thymoma derived cell lines that
are of an undetermined stage of lymphocyte develop-
ment (Cook, 1985; Cook and Balaton, 1987; Holland
et al., 1991). Since the Thy-1l category of A-MuLV
transformed thymomas may be relevant to early lym-
phocyte development (Clark et al., 1993; Cook, 1985;
Cook and Balaton, 1987; Holland et al., 1991), it is
important to better characterize these tumor cells and
the normal thymocyte population that gives rise to
them. Even though there are certain advantages to
characterizing tumor populations by analyzing cell
lines derived from them, we initially chose to charac-
terize the Thy-11 cells in the primary thymomas in
order to minimize phenotypic changes that often
occur during adaptation to in vitro culture.
RESULTS
Coexpression of B220 and Thy-1l on immature
lymphocytes in primary thymomas induced
by A-MuLV
We previously reported that thymomas induced by
either v-abl or BCR-ABL oncogenes usually contain
distinct populations of Thy-lhi and Thy-ll cells
(Clark et al., 1993). Further examination revealed that
B220+ cells also were present at approximately the
same frequency as the Thy-1l cells (Clark et al.,
1993). Therefore, we used two-color flow cytometry
to determine whether cells in A-MuLV-induced thy-
momas coexpress Thy-11 and B220+. This analysis
revealed the presence of two major thymoma subpop-
ulations that could be distinguished by their pheno-
type. One subpopulation expressed high levels of
Thy-1 and was B220-. The second subpopulation was
B220+ and expressed Thy-1 at about a 10-fold lower
peak fluorescence than the Thy- lhi population
(Fig. 1). Thus, the Thy-11 subpopulation that we pre-
viously identified in primary thymomas, also coex-
presses B220. However, because the Thy-11 signal
overlaps the isotype controls (data not shown), it is
possible that some B220+ thymoma cells may be
Thy-1-. In contrast to the thymic B220+ tumor cells,
cells from peripheral lymphomas that often appear in
thymoma-bearing mice did not express any Thy-1
signal above the isotype background (data not shown)
which is typical for A-MuLV-transformed pre-B cells.
To further characterize the B220+ subpopulation,
thymoma cells were first enriched over a magnetic
column to >95% B220+ cells, then examined by
immunofluorescent staining for surface Ig, CD2,
CD5, CD43 and heat stable antigen (HSA or llD).
The B220+ cells from all thymomas examined
expressed a homogenous undifferentiated phenotype
(Fig and Table I). Thus, flow cytometry revealed
that B220+ thym0ma cells did not express surface
IgM or Igc. In addition, Western blot analysis and
immunostaining of cytospin preparations both failed
to demonstrate expression of Cg in any of the B220+
tumor subpopulations. In contrast, using these meth-
ods we did detect Ct in normal spleen cells as well as
in A-MuLV transformed bone marrow controls (data
not shown). Flow cytometry further showed that
B220+ tumor cells were CD5- and CD2neg-l but
expressed uniform levels of both CD43 and HSA
(Fig. 1 and data not shown). These phenotypic data
are summarized in Table I.
Both Thy-1+ B220" and Thy-1l B220+ thymoma
populations arise from A-MuLV-infected cells
To determine whether the different thymoma subpop-
ulations arose from A-MuLV-infected cells, we first
attempted to use DNA blot hybridization to examine
the pattern of proviral integration. Thymoma popula-
tions were sorted on the basis of B220 expression
over the magnetic column and a small amount ofLYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 5
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FIGURE 2 Semiquantitative PCR measurement of relative proviral content shows that the B220 and B220- thymoma subpopulations both
arose from A-MuLV infected cells. After magnetically sorting thymomas into B220+and B220- fractions, their DNA was amplified using
primers that span a 491 bp gag-abl fragment and a 737 bp a-actin fragment which served as an internal amplification control. The relative
proviral content was determined by normalizing the gag-abl signal to the actin signal. Lanes 1-5: Amplification standards were prepared by
mixing DNA from normal liver and from the v-abl transformed cell line, LPC 5-9, in different proportions. Lanes 5-8: v-abl transformed
pre-B cell lines. Lanes 9-14: sorted B220 thymoma cells. Bands were visualized and quantitated by Phosphorimager (Molecular Dynamics)
from which the ratio of the gag-abl to the actin signal was calculated.
DNA was extracted from the subpopulations. The
DNA was digested witl EcoRI, which does not cut
within the A-MuLV genome, and then processed for
Southern blot hybridization with a v-abl probe. DNA
from the B220+ and B220- subpopulations revealed a
30 kb c-abl genomic band along with several unclear
bands of submolar hybridization intensity and/or a
smear running from about 9-30 kb. These results
were repeated on several Southern blots ofDNA from
column sorted tumor subpopulations (data not
shown), which suggests that the subpopulations were
oligoclonal with respect to proviral integration, as we
previously reported for the unsorted thymomas (Clark
et al., 1993). This fact prevented a close comparison
of proviral integration in the different subpopulations
that coexisted within individual thymomas. On the
other hand, DNA obtained from several unsorted
peripheral lymphomas revealed single distinct provi-
ral bands for each tumor along with a strong signal
from the 30 kb c-abl band. Therefore, unlike the thy-
momas, peripheral lymphomas were clonal in origin.
Because it was difficult to obtain high resolution on
DNA blots of the sorted subpopulations, we used the
PCR strategy illustrated in Fig. 2 to quantitate the rel-
ative proviral content in order to evaluate the contri-
bution of A-MuLV infected cells to each sorted tumor
subpopulation. Bands from the PCR reactions were
quantitated by Phosphorimager and the relative provi-
ral content of each subpopulation was calculated as
the intensity of the 491 bp proviral gag-abl band nor-
malized to the intensity of the 737 bp actin band.
These values were checked against the proviral con-
tents of standards prepared by serially diluting DNA
from a v-abl transformed pre-B cell line with DNA
from normal liver (Fig. 2, lanes 1-5). In the sorted
B220+ (Fig. 3, lanes 9-14) and B220- (data not
shown) tumor subpopulations, the mean relative
proviral content was 0.7 (range 0.5-1.0), which was
somewhat higher than the 0.5 mean relative proviral
content of four clonal v-abl transformed bone marrow
cell lines (Fig. 3, lanes 5-8, range 0.4-0.5). Neverthe-
less, this confirmed that both B220+ and B220- thy-
moma subpopulations were infected with A-MuLV.6 ERIC Y. CHEN et al.
TABLE
Thymoma
Ab staining PCRb DNA blot
B220 Thyl CD2 CD5 CD43 HSA slg Ct VDJH DJH IgH Igl TCRy TCR
Ao
Bo
26.9 pos 1o 1o neg pos pos neg 4% 24%
21.2 pos 1o -6% 29%
21.1 pos lo 8% 44%
21.5 pos 1o 1% 48%
24.1 pos 1o 9% 58%
25.1 pos 1o neg pos pos neg 5% 58%
25.7 pos 1o 1o neg pos pos neg neg 7% 63%
25.9 pos lo neg neg pos pos neg 7% 66%
Rg GG GG GG
Rg GG GG GG
Rg GG GG GG
25.2 pos lo neg pos pos neg 23% 37%
26.7 pos lo neg neg pos pos neg 21% 38% rG GG
25.5 pos lo 1o neg pos pos neg neg 15% 60% Rg GG GG GG
C. 23.9 pos lo 32% 34%
23.3 pos lo 60% 54%
D, 26.8 pos lo lo neg pos pos neg GG GG
25.8 pos lo neg neg pos pos neg RR GG GG GG
(21.3) pos lo neg R(g) GG (r)G GG
(23.5) pos lo neg R(g) GG (r)G GG
(24.3) pos 1o neg R(g) GG (r)G GG
(24.5) pos io R(g) GG GG GG
25.7 neg hi -6% 15% GG GG Rg Rg
24.1 neg hi 2% 22%
25.9 neg hi 2% 26% rG GG rG Rg
25.1 neg hi 5% 36% rG GG
25.5 neg hi GG GG
26.8 neg hi rG Rg
26.7 neg hi GG GG Rg Rg
(22.7) neg hi neg GG GG R(g) R(g)
(22.3) neg hi GG GG R(g) R(g)
Eo
G. (22.3L) pos neg neg RR GG GG GG
(21.3L) pos neg neg RR GG GG GG
H. LPC 5-9 pos neg pos 69% 82% RR GG . Thymoma samples were sorted by anti-B220 magnetic column, except for those marked in parenthesis which were not sorted because
they were >85% B220 or >85% Thy-1 hi. "L" denotes that the sample was a peripheral lymphoma that arose in an intrathymically injected
animal. Thymomas are grouped based upon B220 phenotype and the extent of Igh rearrangement as determined by PCR according to the
following scheme: (A) B220 thymomas with only DJH rearrangement. (B) B220 thymomas with less VHDJH than DJH rearrangement.
(C) B220 thymomas with equivalent VHDJH and DJn rearrangement. (D) B220 thymomas only analyzed by Southern blot. (E) B220-
thymomas analyzed by PCR. (F) B220- thymomas only analyzed by Southern blot. (G) B220 peripheral lymphomas. (H) Bone marrow
derived v-abl cell line.
b. The extent of rearrangement of the Igh gene is presented as the mean percent loss of germline structure as illustrated in Fig. 4. The values
represent the mean from 3-6 separate amplifications from each sample. Standard errors of the mean percentage loss were <7%. <10% loss
of germline is considered as no rearrangement. Rearrangement of the lg: light chain gene was not detected in any samples tested.
c. GG=germline configuration on both alleles, RR=complete rearrangement of both alleles, rG=minor rearrangement detected with pre-
dominant germline band, Rg=significant rearrangement detected with minor germline band. Parentheses indicate that the minor band could
be attributed to contaminating cells in unsorted thymomasLYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 7
Significant subpopulations of Thy-1l
B220+A-MuLV transformed thymoma cells
do not demonstrate Ig or TCR gene rearrangement
In order to assess the extent of antigen receptor gene
rearrangement in the Thy-11 B220+ subpopulation,
DNA was extracted from thymoma subpopulations
that were sorted for B220 expression on the magnetic
column. The DNA was analyzed either by PCR
amplification for Igh rearrangement or by Southern
blot for TCR rearrangement. The PCR strategy for Igh
rearrangement allowed DJH and VHDJH rearrange-
ment to be measured as a loss of germline structure
relative to unrearranged liverDNA (Fig. 3A). In order
to confirm that this analysis was quantitative, liver
DNA was serially diluted with DNA from an
A-MuLV transformed pre-B cell line, LPC 5.9, ampli-
fied by PCR (Fig. 3A), and the loss of Igh germline
was determined by normalizing the unrearranged
signal to the amplified actin signal. Figure 3B shows
that the measured loss of Igh germline is linear and
strongly correlates with the expected Igh rearrange-
ment (correlation coefficient r .994 for loss of VII to
DJH germline and .997 for loss of D to JH germline).
An example of this analysis is shown in Fig. 3C for
sorted subpopulations from thymoma 25.7 (lanes 4
and 5) and from subclones of a marrow derived
A-MuLV-transformed cell line that were selected for
different patterns of Cp expression (lanes 2 and 3).
The data show that while both B220+and B220- sub-
populations of the thymoma had failed to rearrange
VII to DJH, the B220+ thymoma subpopulation had
undergone significantly more D to JH rearrangement
than the B220- subpopulation (74% vs 18%). In con-
trast to the thymoma subpopulations, an A-MuLV
transformed pre-B cell line that expressed Ct (lane 3)
showed 74% and 98% loss ofVH to DJH and D to JH
segments, respectively, while a less differentiated
A-MuLV pre-B cell line that did not express Ct (lane
2) only lost 22% and 94% of VH to DJH and D to JH
segments, respectively.
Similar PCR analysis showed that 8 of 13 Thy-11
B220+ subpopulations examined had lost <10% of VII
to DJH germline structure (Table IA) which was not
statistically different (Student’s t-test) from the mean
germline content of eight control liver samples. Cells
from the eight Thy-11 B220+ tumors that had not
rearranged VH to DJH demonstrated variable DJH
rearrangement. Two showed 20-30% loss of D to jH
germline structure, two lost 40-50%, and four lost
about 60% of the germline structure (Table IA). The
remaining five Thy-11 B220+ thymoma subpopula-
tions that were examined (Table IB and 1C) demon-
strated significant VH to DJH rearrangement (15-
60%). Three of these subpopulations showed 2-4 fold
more rearrangement (37-60%) of D to JH than VH to
DJH sequences (Table IB). In contrast, the Thy-11
B220+ subpopulation from tumors 23.3 and 23.9
showed approximately equivalent VII to DJH and D to
JI-I rearrangement (Table IC). Southern blot analysis
of. Igh rearrangement also was performed on some
tumor populations, the results of which were in close
agreement with the PCR data (Table IA and 1B and
data not shown). In addition, four unsorted thymomas
that were >85% B220+ were analyzed by Southern
blot only which revealed predominantly Igh germline
structure (Table ID); None of the Thy-1 B220+ thy-
moma subpopulations showed rearrangement of IgK
light chain genes either by DNA blot or by PCR anal-
yses (Tables IA, 1B, 1C).
The Thy-1 B220+ thymoma cells also did not
demonstrate significant TCR’ or TCR rearrangement
by Southern blot analysis (Fig. 4A and B, lanes 1, 3,
5, 7, 8 and data not shown). After hybridizing with the
TCR probe, the blots were stripped and rehybridized
with a c-myc probe to normalize for DNA loading
(Fig. 4C). Rearrangement of TCR/and TCR genes
was quantitated by measuring the loss of germline
bands with a Phosphorimager after normalizing to the
level of the c-myc gene detected in each lane. Some
Thy-1 B220+ tumor samples showed up to 16% loss
of the TCR/or germline signal (Fig. 4D); however,
this minimal rearrangement can be partly attributed to
the 5% contamination with Thy-1 hi B220- cells from
the magnetic column sorting process. In addition,
with this method of quantitation, the level of germline
TCRDNA detected in seven different liverDNA sam-
ples varied by 7% relative to the c-myc control (data
not shown). Thus, we conclude that in the six Thy-118 ERIC Y. CHEN et al.
V OH
1227 bp DFLI&_I__I
472 bp
1 2 3 4 5 6 7 8 9
% liver DNA: 100 88 75 63 50 37 25 12 0
% LPC DNA: 0 12 25 37 50 63 75 88 100
al
1.6
t.4
12
0.8
0.6
0.4
0.2
0.994
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
V to DJH rearrangement
E 1.8
,_Oil 1.6
II 1.4
0.997
1 2 30% 4 5 60% 7 80% % 10
D to JH rearrangement
lIIO: + + +
% VOJH rearrangement: 0 22 74 7 0
FIGURE 3 (A) Quantitative PCR strategy to measure VH to DJH and D to JH reaangement in soed thymoma populations. The strategy is
based upon PCR amplification of intervening regions &at are lost upon immunoglobulin assembly so &at reaangement can be measured as
the percent loss of germ]ine DNA. Loss of the 472 bp JH #agment indicates D to JN reaangement and loss of&e 1227 bp DFL16.1#agment
indicates VH to DJH assembly. The 737 bp -actin #agment was amplified along with immunoglobulin #agments to serve as an internal
amplification control for quantitation. DNA #om normal liver and a v-abl transformed pre-B cell line (LPC 5-1) were mixed together in the
indicated propoions and all three sequences were amplified in the same tube. The bands were visualized and quantitated by Phosphorim-
ager. (B) The reaangement ofVH to DJH and ofD to JH sequences was measured by normalizing the intensity of each amplified band to &e
amplified actin product, and &is normalized signal was plotted against the expected percent loss of germline structure in ee dilution series.
The co,elation coefficients, h are indicated and show a linear co,elation between the measured loss of germline DNA with the expected
degree of Igh reaangement. (C) A representative experiment shows that the magnetically sorted B220 and B220- subpopulations #om thy-
moma 25.7 exhibit different degrees ofIgh reaangement. Neither subpopulation showed @preciable loss of the VH to DJH germ]ine region,
but differed in &e degree of reaangement of D to JH. Lane 1: liver DNA, Lanes 2-3: C# and C#- maow-derived A-MuLV pre-B cell
lines (both subclones of LPC 5-9). Lanes 4-5:B220 and B220- subpopulations sorted from thymoma 25.7. The C# and B220 phenotypes,
as well as percent loss ofVH to DJH and D to JH germline structure are listed below the figureLYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 9
B220+ thymoma subpopulations that were examined,
negligible rearrangement of TCR genes has occurred.
In contrast to the Thy-ll B220+ thymoma subpop-
ulation, Thy-1 hi B220- tumor cells (Fig. 4A and 4B,
lanes 2, 4, 6, and 9) and normal thymus (lane 14)
showed extensive rearrangement of both TCR’ and
TCR[3 genes by DNA blot analysis. TCR’ rearrange-
ment was evident by 33-68% loss of germline
bands (Fig 4D, lanes 2, 4, 6, and 9) and by the appear-
ance of rearranged bands (Fig 4A, lanes 2, 4, 6, and
9). TCR rearrangement was also apparent by the 54-
59% loss of the CI31 germline band (Fig. 4B and 4D,
lanes 2, 4, 6, and 9). Since the TCR3 probe detects the
3’ untranslated region of C31 and does not
cross-hybridize with C[2, complete loss of the C131
germline sequences without the appearance of rear-
ranged bands in these oligoclonal populations is
likely due to rearrangement involving C12 (Clark et
al., 1993). In contrast to this extensive rearrangement
of TCR genes in the Thy-lhi B220- thymoma subpop-
ulation, PCR analysis of Igh genes revealed minimal
(15-36%) loss of DH to JH germline and negligible
(<10%) loss ofVH to DJH germline sequences, which
was confirmed by the DNA blots (Table IE). In the
Thy-1hi B220- thymomfi cells, this pattern of minimal
lgh and extensive TCR/and 3 rearrangement is con-
sistent with a T-cell lineage origin.
Like the B220+ thymoma subpopulation, the B220+
peripheral lymphomas showed negligible rearrange-
ment of TCR’ and TCR[3 (fig 4A and B, lanes 11 and
12). However, unlike the thymoma subpopulation,
these B220+ lymphomas were entirely Thy-1- and
demonstrated complete loss of Igh germline structure
on both alleles by Southern blot (Table IG). This pat-
tern is, as expected, consistent with a B-cell lineage
origin of the A-MuLV lymphoma population. None of
the tumor populations or cell lines that were exam-
ined showed rearrangement of Ig light chain genes
by DNA blot analysis or by PCR analysis (Table I).
The concentration ofA-MuLV can affect
the transformation of different thymic targets
The Thy-11 B220+ and Thy-1 hi B220- tumor subpop-
ulations that co-exist in the thymomas could arise
either from the transformation of different thymic
lymphocyte targets or by the divergent maturation of
a transformed lymphocyte progenitor. We reasoned
that if different thymic targets were transformed by
A-MuLV, altering the virus titer might affect the
selection of different targets for A-MuLV transforma-
tion. On the other hand, if both thymoma populations
did arise from the same transformed target, then the
virus titer would not affect the proportional represen-
tation of each population in individual thymomas.
A freshly prepared stock of A-MuLV (105 ffu) was
either concentrated 10-fold or diluted 10-fold in cul-
ture media prior to intrathymic injection. The median
latent period for tumor formation (35-38 days) was
similar in mice injected with the different concentra-
tiQns of A-MuLV (data not shown). B220 and Thy-1
expression were evaluated by two-color flow cytome-
try and the data are summarized in Fig. 5. All tumors
induced with the diluted (0.1x) virus primarily con-
sisted of Thy-11 B220
/ cells and none of the thymo-
mas in this group were predominately Thy-1 hi B220-.
In contrast, 70% of the tumors induced with the 10x
concentrated virus were almost entirely Thy-1 hi
B220-, and an intermediate fraction (20%) of tumors
from animals injected with the neat virus developed
predominately Thy-1 hi B220- thymomas. Although
the Thy-1 hi B220- thymomas were phenotypically
indistinguishable from thymomas induced by
Mo-MuLV alone (Clark et al., 1993), all tumors that
developed in mice injected with the different
A-MuLV concentrations expressed the P160v-a/’l
product (data not shown). In addition, all
A-MuLV-induced tumors arose after a significantly
shorter latent period (range 22-56 days, data not
shown) than expected for thymomas induced by
intrathymic injection with Mo-MuLV alone (range
81-157 days) (Clark et al., 1993).
Rare B220+ cells in normal thymi do not contain
targets for in vitro transformation
In bone marrow a Thy-11 B220+ B-lymphoid progen-
itor population is highly enriched for A-MuLV trans-
formation targets (Tidmarsh et al., 1989). Since this
phenotype is similar to the A-MuLV-transformed thy-10 ERIC Y. CHEN et al.
1 2 3 4 5
+ + +
7 8 9 10 tl 12 13 14
23.1
J72 {tlTkb}
44 4 co,m (47kb)
7 36 16 68 8 33 4 13 57 0 5 14 0 77
t3 58 9 54 ’1 59 5 3 59 0 4 2 0 92
FIGURE 4 DNA blot analysis of TCR rearrangement. HindIII digested genomic DNA from B220 sorted thymomas (lanes 1-9) or from
extrathoracic lymphomas (lanes 11,12) were examined for rearrangement of TCRy (A) and TCR# (B). A c-myc probe was used to quantitate
the relative amount ofDNA loaded in each lane (C). In order to measure the loss of germline structure, bands were quantitated by phospho-
rimaging and the ratio of the TCRy or TCR germline signal to c-myc in the tumor populations was compared to a similarly normalized con-
trol ratio from unrearranged liver DNA (D). The TCRy germline signal was measured by comparing the signal from individual J/1-3
germline bands to the c-myc control. Lanes and 2:B220 sorted fractions from thymoma 25.9. Lanes 3 and 4:B220 sorted fractions from
thymoma 25.7. Lanes 5 and 6:B220 sorted fractions from thymoma 26.8. Lane 7:B220 sorted fraction from thymoma 25.1. Lane 8:B220
sorted fraction from thymoma 25.5. Lane 9: B220- sorted cells from thymoma 26.7. Lanes 10 and 13: normal liver. Lanes 11 and 12: periph-
eral lymphomas from mice 21.3 and 22.3, respectively. Lane 14: normal thymus. The arrowheads point to unrearranged germline bands
moma population described in this report, we exam-
ined normal adult thymi for a similar lymphoid
progenitor target susceptible to in vitro transformation
by A-MuLV. Flow analysis revealed that only 0.3% of
all thymocytes express B220. Therefore, the B220+
cells were first enriched approximately 100-fold over
an anti-B220 magnetic column and then examined for
co-expression of other surface antigens by flow
cytometry. This revealed that B220+ thymocytes rep-
resent a heterogeneous population in which about
50% express surface IgM and IgK. About 40% of the
thymic B220+ population were also Thy-1l which
resembled the Thy-ll B220+ thymoma subpopula-
tions as well as the marrow-derived B-cell progeni-LYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 11
tors that are targets for A-MuLV transformation
(Tidmarsh et al., 1989). For this reason, we tested the
ability ofA-MuLV to transform B220+ thymocytes in
vitro. As shown in Table II, B220+ bone marrow cells
were enriched in targets for in vitro transformation by
A-MuLV. Conversely, in three different experiments,
B220+ cells from normal thymi never showed in vitro
transformation by A-MuLV, even when plated over a
bone marrow stroma with exogenous IL-7, conditions
that greatly enhanced transformation of bone marrow
pre-B cells (data not shown). In order to test whether
contaminating thymocytes in the sorted populations
could actively inhibit in vitro transformation of a rare
pro-B cell, thymocytes and normal bone marrow were
admixed prior to infection. No inhibition of in vitro
transformation was detected (data not shown). Thus,
B220+thymic lymphocytes are distinct from B220+
bone marrow lymphocytes in their ability to be trans-
formed in vitro by A-MuLV.
DISCUSSION
B220+ thymoma cells resemble early lymphoid
progenitors
We demonstrated that two distinct tumor subpopula-
tions often co-exist in A-MuLV induced primary thy-
momas. The subpopulation that was B220- was also
uniformly Thy-1 hi and had extensively rearranged
TCR, TCR7 and DJH regions but not VH. This sub-
population, therefore, consists ofA-MuLV transformed
T-lymphoid cells, similar to A-MuLV-transformed thy-
mic cell lines that have been described by others (Clark
et al., 1993; Cook, 1982; Cook, 1985; Cook and Bala-
ton, 1987; Holland et al., 1991; Risser et al., 1985;
Scott et al., 1986; Heuze et al., 1992). The other major
thymoma subpopulation was B220+ and expressed low
levels of Thy-1. This subpopulation had not rearranged
TCR genes, but had undergone variable rearrangement
ofIgh genes. This population is interesting since it con-
tained a significant proportion of cells that apparently
have not rearranged any antigen receptor genes and,
therefore, cannot be assigned to either the B or T-lym-
phoid lineage.
The Thy-11 B220+ thymoma subpopulation exhib-
ited a composite phenotype that also was consistent
with immature lymphoid cells (CD43+ HSA+ CD5-
CD2neg-l sIg- Ct-) but that was not specifically char-
acteristic of either the B or T-lymphoid lineage.
Co-expression of Thy-ll B220+ CD43+ HSA+ and
negligible expression of CD2 is consistent with a
pro-B cell phenotype (Hardy et al., 1989; Hardy, et
al., 1991; Li et al., 1996; Nutt et al., 1997; Rolnick et
al., 1996; Sen et al., 1990; Winkler et al., 1995; Yagita
et al., 1989) and similar to the phenotype ofA-MuLV
transformed bone marrow pre-B cells (Rosenberg and
Kincade, 1994). However, the fact that a significant
proportion of these cells had not rearranged Igh genes
is inconsistent with the observation that they express
HSA which first appears on B lymphocyte progeni-
tors in the process of rearranging the D to JH region
(Allman et al., 1999; Nutt et al., 1997).
TABLE II B220 thymocytes are not transformed in vitro
A-MuLV target population Percentage oftotal population Number ofcolonies/lO6 plated cells Percentage oftotal targetsb
Bone marrow:
Unseparated 100% 1,028 100%
B220 40% 12,273 83%
B220- 60% 231 17%
Thymus:
Unseparated 100% 0
B220 0.3% 0 0%
B220- 99.7% 0 0%
See materials and methods for experimental protocol. Data are representative of three separate experiments.
b. The percentage of total targets for a given subpopulation (Px)/(PxI+ Px2 +... + Pxn) where X1, X2 Xn are n subpopulations
defined by flow cytometry and each infected separately with A-MuLV and subsequently plated in soft ggar. Px % of subpopulation X in
the total unsorted population) (number of emergent colonies fro subpopulation X, standadized to 10 plated cells)"12 ERIC Y. CHEN et al.
The composite phenotype of the Thy-11 B220+
thymoma subpopulation also is not inconsistent with
the phenotype of primitive cortical T-cells. Even
though the majority of thymocytes are Thy-lhi CD2
/
CD5
/ HSA1 (Duplay et al., 1989), an early cortical
pro-thymocyte subpopulation expresses a Thy-11
CD2-CD5- HSAhi phenotype (Duplay et al., 1989;
Scollay and Shortman, 1985). As the cells mature,
expression of CD2 and CD5 increase (Duplay et al.,
1989; Sen et al., 1989) while HSA levels decrease
(Scollay and Shortman, 1985; Crispe and Bevan,
1987). Additionally, while expression of B220 is
more often associated with cells of the B-lymphoid
lineage, there are several examples of B220 expres-
sion on immature T-cells. For instance, B220
/
Thy-1neg-hi pro-T cell lines transformed with v-abl
(Heuze et al., 1992), v-myc (Brightman et al., 1988)
and RadLV (Ho and O’Neill, 1993) have been
reported. In addition, autoimmune-prone strains of
mice often carry B220
/ T-lymphocytes (Matsuzaki et
al., 1992; Landolfi et al., 1993; Giese et al., 1994)
which develop from thymic B220
/ progenitor cells
(Budd et al., 1985; Asensi et al., 1990). However,
while these cells are usually found in autoim-
mune-prone mice and express CD5, the Thy-1l
B220+ thymoma subpopulation was uniformly CD5-.
The B220 antigen was also reported to be expressed
on a minor subpopulation of immature CD4-8- double
negative (DN) thymocytes from normal mice (Gause
et al., 1988) as well as on DN thymocytes undergoing
apoptosis (Mixter et al., 1999). Finally, rare B220+
lymphoid progenitor cell populations from the bone
marrow (Onishi et al., 1993) and from fetal liver
(Sagara et al., 1997) reportedly are able to repopulate
the thymus (but see Morrison et al., 1994). Therefore,
the fact that immature T-cells can sometimes express
B220 makes the composite phenotype of the Thy-1l
B220+ thymoma population consistent with immature
cells in the T as well as B-lymphoid lineages. We con-
clude that, based on surface antigen phenotype alone,
the A-MuLV transformed Thy-11 B220+ thymoma
cells are not easily assigned to either the B or T-lym-
phoid lineage.
100
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30--
0
lOX lX 0.1X
relative A-Mul_V titer
FIGURE 5 The frequency of Thy-11 B220 cells in A-MuLV induced tumors correlates with virus titer. Mice were intrathymically injected
lo with the same volume of 10X (n=10), 1X (n=33)or 0.1X (n=6)concentrations ofA-MuLV and the percentage of Thy-1 B220 cells in each
lo thymoma was determined by flow cytometry. The mean and standard error for the frequency of Thy-1 B220 cells in each group is also
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Overall the immature Thy-11 B220+ cells did not
appear to have rearranged TCR,, TCR, or Ign genes;
however, in some thymomas, minor subpopulations
of Thy-11 B220+ cells appeared to have undergone
VII to DJH rearrangement and, therefore, probably
represent transformed thymic pre-B cells similar to
those described by others (Cook, 1982; Cook, 1985;
Cook and Balaton, 1987; Holland et al., 1991; Kimoto
et al., 1989; Risser et al., 1985; Scott et al., 1986).
More interesting are those Thy-11 B220+ thymoma
populations that, based on the predictable events of Ig
gene assembly (Schatz et al., 1992), contained a sig-
nificant number of cells that had not rearranged Igh
genes. For example, <30% of the Thy-1l B220+ pop-
ulation in thymomas 26.9 and 21.2 showed loss of D
to JH germline structure and no loss ofVH to DJH ger-
mline sequences (Table IA) and, therefore, appeared
to be similar to A-MuLV transformed cell lines that
have only rearranged DJH (Ramakrishnan and Rosen-
berg, 1988; Wang and Rosenberg, 1993). This also
means that either a maximum of 30% of the popula-
tion has rearranged both DJH alleles or, that up to
60% of the cells have only rearranged one DJH allele.
Therefore, we conclude that 40-70% of the Thy-1l
B220+ cells in these thymomas have not undergone
DH to J rearrangement and may represent transformed
undifferentiated lymphocytes.
The Thy-1 B220+ cells in thymomas 23.3 and
23.9 showed a somewhat different pattern of Igh rear-
rangement (Table IC). In both thymomas, these cells
apparently lost equal amounts of D to JH and VH to
DJH germline segments. Since VH rearrangement
does not occur until D to JH assembly has occurred on
both alleles (Schatz et al., 1992), it is reasonable to
conclude that the cells that showed loss of Ig germline
structure had completed VHDJH rearrangement on
both alleles. It would follow that the remaining cells
in these tumors maintain Igh genes in germline con-
figuration. For instance, thymoma 23.3 lost about
30% and 40% of D to JH and VII to DJI_ germline
sequences, respectively. Therefore, the remaining
70% of the cells in the Thy-l B220+ population in
these tumors probably have not undergone Igh rear-
rangement and are undifferentiated lymphocytes.
Thymomas 25.2 and 26.7 showed yet another pat-
tern of Ig rearrangement, in which twice as much DH
to JII germline structure was lost compared to VH to
DJII germline structure (Table IB). Both thymomas
showed about 40% loss of unrearranged DH to JH
structure and 20% loss of VH to DJH germline
sequences. Since both DJH alleles rearrange prior to
VH to DJH rearrangement, it is possible that up to
40% of the Thy-11 B220+ thymoma cells have rear-
ranged DH to JH on both alleles and VH to DJH on one
allele. This would mean that the remaining 60% of the
thymoma population have not rearranged Igh genes.
However, in these tumors, it is also possible that up to
20% of the tumor population completed Vt to DJH
rearrangement on both alleles. In this case, then, DJII
rearrangement would be found on another 20-40% of
the population, depending on whether the cells rear-
ranged one or both alleles. This means that a mini-
mum of 40% of the cells in these thymoma
populations appear to be undifferentiated lympho-
cytes that have not undergone Igh rearrangement.
Together, the quantitative PCR data along with the
Southern blot data demonstrate that in some tumors as
much as 70% of Thy-1 B220+ cells have not rear-
ranged either Ig or TCR genes, and, therefore, resem-
ble the earliest lymphoid progenitor. This
progenitor-like subpopulation is distinct from most of
the previously described A-MuLV-transformed thy-
moma cell lines, all of which have undergone signifi-
cant rearrangement of their Ig and/or TCR genes
(Clark et al., 1993; Cook, 1982; Cook, 1985; Cook
and Balaton, 1987; Holland et al., 1991; Kimoto et al.,
1989; Risser et al., 1985; Scott et al., 1986). Never-
theless, the Thy-l B220+ progenitor-like cells in the
primary thymomas do share similarities with some
other transformed lymphoid populations. For
instance, these progenitor-like lymphocytes closely
resemble thymomas that arise in bcl-2/myc transgenic
mice (Strasser et al., 1990) and that are Thy-1
B220+ sIg- and have not rearranged T or B lympho-
cyte antigen receptor genes. It is conceivable that
A-MuLV and the bcl-2/myc transgenes may transform
a similar lymphoid progenitor population. Also, Hol-
land et al. (1991), described an A-MuLV-transformed
thymoma cell line that was Thy-1neg-l B220+ and14 ERIC Y. CHEN et al.
that only had minimal Igh rearrangement within a
subpopulation of the line. These cells were capable of
rearranging TCRy genes after intrathymic injection
and of continuing Igh rearrangement in vitro. It is an
intriguing possibility that the Thy-1 lo B220+ progeni-
tor-like cells found in our primary thymomas repre-
sent an A-MuLV-transformed thymic lymphocyte
progenitor (Carlyle et al., 1997; Wu et al., 1991) that
also may be capable of undergoing differentiation
along the T and/or B-cell pathways. However, in light
of the recent observation that commitment to the B
lymphoid lineage may occur before D to JH recombi-
nation (Allman et al., 1999), it is possible that these
progenitor-like thymoma cells may already be com-
mitted to either the T or B lymphoid lineage. Experi-
ments are underway to attempt to resolve this issue.
Thymic targets for A-MuLV transformation
The progenitor-like thymoma population expressed a
Thy-11 B220
/ phenotype that is similar to bone mar-
row derived B-lymphoid progenitors that are enriched
for A-MuLV transformation targets (Tidmarsh et al.,
1989). This similarity raised the possibility that a
B-cell progenitor in the adult thymus is a target for
transformation by v-abl. However, unlike the bone
marrow B220
/ cells, thymic B220
/ cells could not be
transformed in vitro by A-MuLV. On one hand, it is
possible that the thymocyte transformation target that
gives rise to the Thy-11 B220
/ progenitor-like
A-MuLV transformants is not found within the nor-
mal B220
/ thymocyte subpopulation even though
40% of these cells also expressed Thy-11. However,
it is also possible that A-MuLV transformation of a
thymic B220
/ pro-lymphocyte can only occur within
a thymic microenvironment, which would explain our
inability to transform these cells in vitro. Either way,
there appear to be fundamental differences between
the transformation targets in the bone marrow vs the
thymus that give rise to B220
/ transformed cells.
The co-existence of A-MuLV-transformed pre-B
and pre-T cells in primary thymomas raises the ques-
tion of whether these different populations arise from
the transformation of the same or different target
cells. The presence of pre-T and pre-B cell transfor-
mants in the same thymoma could feasibly arise from
A-MuLV infection of separate T and B cell progeni-
tors that may be present in the adult thymus; however,
the surprising inability to transform thymic B cell
progenitors in vitro is not consistent with this expla-
nation. Alternatively, the coexisting pre-T and pre-B
cell thymoma populations could feasibly arise from
transformation of an undifferentiated lymphocyte pro-
genitor that may undergo T- and B-lymphopoiesis
after transformation by A-MuLV (Whitlock et al.,
1983). However, it seems unlikely that the coexisting
Thy-1hi B220- and Thy-11 B220
/ thymoma subpopu-
lations arose from the transformation of a single target
cell because intrathymic injection of different concen-
trations of A-MuLV induced thymomas with distinct
phenotypes. If both thymoma populations arose from
transformation of a single target cell, it is unlikely that
the virus titer would affect their proportional repre-
sentation in the tumors.
In summary, these observations suggest that a sub-
set of the Thy-11 B220
/ thymoma population repre-
sents an undifferentiated lymphoid progenitor that
cannot be unequivocally assigned to either the T or
B-lymphoid lineage. It will be of interest to identify
the normal thymocyte target that gives rise to this
transformed progenitor population and to assess its
capacity for differentiation.
MATERIALS AND METHODS
Retrovirus
A-MuLV (1-2 x 105 focus forming units per ml) was
collected from clonal NIH 3T3 fibroblast cells
infected with a helper-free A-MuLV and superin-
fected with Moloney murine leukemia virus
(Mo-MuLV). To make a concentrated preparation of
A-MuLV, viral supernatant was centrifuged over a
20% sucrose cushion, and the virion pellet was gently
resuspended in 0.01 volumes of media (Wang et al.,
1991). The virus was quantitated by slot blot hybrid-
ization which showed a 50-fold enrichment of viral
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of infectious virus by measuring v-abl oncoprotein
expression in acutely infected NIH 3T3 fibroblasts
revealed a 10-fold concentration of active virus.
Tumor cell preparation
Thymic lymphomas were induced in 4-5-week-old
female BALB/c mice (Harlan-Sprague-Dawley, Indi-
anapolis, IN) by intrathymic injection of A-MuLV as
previously described (Clark et al., 1993). Thymomas
arising in individual mice are identified according to
the experiment and animal number. Thus, thymoma
25.2 identifies the second animal to develop thymic
lymphoma in experiment number 25. Cell suspen-
sions were made from thymomas or peripheral lym-
phomas and were either processed immediately for
immunophenotype analyses or were cryopreserved.
Upon thawing cryopreserved samples, dead cells
were removed by agglutination in high phosphate
buffered saline or by filtration through glass wool
(Mishell et al., 1980).
Preparation of normal thymocytes
3-4 week-old female BALB/c mice were injected
intraperitoneally with 0.1 ml India ink diluted 1:5 in
PBS. After 20 minutes, mice were sacrificed by CO2
inhalation and perfused by intracardial injection of
10ml ice cold staining buffer [HBSS (without
CaCO3, MgC12, MgSO4, NaHCO3, or phenol red)
containing 0.5% charcoal treated, dialyzed BSA
(fraction V, Sigma Chemical Company, St. Louis,
MO) and 10 mM NAN3]. The thymus was removed
and prepared by removing visible blood vessels and
India ink stained parathymic lymph nodes.
Magnetic cell separation of thymic lymphocytes
For phenotypic and genotypic analyses of B220+ cells
in tumor populations that also contained B220- cells,
B220+ cells were separated over a magnetic column
as described by others (Miltenyi et al., 1990). Basi-
cally, cells were incubated with RA3-6B2-coupled
superparamagnetic microbeads (anti-B220; Miltenyi
Biotec Inc., Sunnyvale, CA) at 10 gl anti-B220 beads
per 107 thymoma cells, or at 10 gl per 108 normal thy-
mocytes. After 10 min., biotinylated RA3-6B2
(Pharmingen, San Diego, CA) (2.5 gg/ml) was added
and the cells were incubated for an additional 20 min-
utes at 4C. This permitted indirect immunofluores-
cent detection of B220 expression of column sorted
populations. Cells were washed in cold staining
buffer and passed over a magnetized A2 separation
column according to the manufacturer’s protocol
(Miltenyi Biotec Inc.). Cells that flowed through were
collected as the B220- fraction. To collect the B220+
fraction, the column was removed from the magnetic
field and the adherent cells were washed from the col-
umn with cold staining buffer. The efficiency of sepa-
ration was assessed by flow cytometry after staining
with avidin conjugated fluorescein-isothiocyanate
(FITC) (Becton-Dickinson, Mountain View, CA).
From thymomas with mixed populations of B220-
and B220+ cells, this protocol routinely gave >95%
B220+ cells from the column and <5% in the
flow-through fraction. From normal thymi where
B220+ cells represented <0.3% of the population,
B220+ cells were enriched 100-fold over the column
and further purified to homogeneity by FACS.
Immunofluorescent cell staining and flow
cytometry
Immunofluorescent cell staining was performed as
described before (Clark et al., 1993), except that cells
were preincubated with FcBlock (Pharmingen) in
order to prevent potential Fc receptor binding of mon-
oclonal antibodies. Strategies for simultaneous analy-
sis of multiple surface antigens were essentially as
described by Hardy et al. (Hardy et al., 1991). After
cells were flow sorted, an aliquot was reanalyzed by
flow cytometry in order to confirm the sorting effi-
ciency. PCR analysis was performed on sorted popu-
lations that were 95-98% pure.
Cell cycle analysis
Simultaneous staining of cell surface antigens and
nuclear DNA was done exactly as described previ-
ously (Schmid et al., 1991).16 ERIC Y. CHEN et al.
DNA blot analysis
DNA blotting procedures and probes used to analyze
tumor clonality and antigen receptor gene rearrange-
ment have been described previously (Clark et al.,
1993). The genomic 4.7 kb c-myc fragment from
pmyc-26 contains c-myc exons 1, 2 and 3 and was
kindly provided by Dr. Richard Schwartz (Michigan
State University).
PCR quantitation of relative proviral content
In order to measure relative v-abl provirus content in
different tumor populations, a 491 bp gag-abl frag-
ment was amplified by PCR using primers specific
for retroviral gag (5’ TCC ACT ACC TCG CAG
GCA TTC 3’) and abl (5’ CCT CCA CCC AAC TTG
TGC TTC 3’) sequences. Amplification of a 737 bp
region of the ot-actin gene (Hardy et al., 1991) was
done in the same tube to serve as an internal amplifi-
cation control. For this PCR analysis, genomic DNA
(25 ng) was first digested with EcoRI, then treated
with 40 tg/ml RNAase (30 minutes at 37C). The
DNA was then added to 100 tl reaction buffer [60
mM Tris-HC1 (pH 9.0), 15 mM (NH4)2SO4, 1.5mM
MgC12] containing 1 tM of each primer and 0.5 U
Taq polymerase (Promega, Madison, WI). Samples
were heated to 80C before 50 tM dNTPs (Promega)
were added. The amplification conditions were 95C
for 1.0 minute, 63C for 0.5 minute, and 72C for 1.5
minutes for 20 cycles. Five tl of amplification prod-
ucts were electrophoresed through 2.5% agarose and
blotted to Gene Screen Plus (NEN Research Products,
Boston, MA). PCR amplification products from a
v-abl transformed pre-B cell line (LPC 5-1) DNA
were gel purified and used as probes. The intensities
of the gag-abl and c-actin amplified signals were
quantitated by Phosphorimager (Molecular Dynam-
ics, Sunnyvale, CA).
PCR analysis of Ig rearrangement
In order to measure the extent of Ig gene assembly in
different tumor populations, quantitative PCR using
primers described by Hardy et al. (Hardy et al., 1991)
was used to amplify Ig gene regions that would be
deleted at different stages of rearrangement. DH to JH
rearrangement was measured by loss of a 472 bp ger-
mline segment that is immediately 5’ of JH 1. VH to
DJH rearrangement was measured by loss of a 1227
bp germline segment 5’ of DFL16.1. V: to J: rear-
rangement was measured by loss of a 435 bp germline
segment immediately 5’ of J:l. PCR amplification of
a 737 bp region of the ot-actin gene was done in the
same tube with the Ig primers to serve as an internal
amplification control as described above.
The parameters for PCR amplification of Ig genes
were identical to those described above, except that
0.1 mg of EcoRI-digested genomic DNA was used as
template, the reaction buffer contained 2.0 mM
MgC12, and 23 cycles of amplification were per-
formed. Unrearranged IgH and IgL products and the
actin fragment amplified from liver DNA were used
as probes. The Ig amplification signal from each
tumor sample was normalized to the actin signal
amplified in the same tube, and this value was com-
pared to a similarly normalized unrearranged Ig
amplified signal from liver in order to quantitate the
loss of Ig germline structure. Each sample was ampli-
fied and analyzed 3-6 times.
Soft agar transformation assay
Bone marrow cells and thymocytes were sorted by
FACStar (Becton-Dickinson) based upon B220 and
Thy-1 expression. Sorted cells were infected with
A-MuLV and then suspended in 0.3% agarose in
IMDM containing the following: 20% FCS, 5x10-5
M 2-ME, 8 mg/ml polybrene, 50 U/ml penicillin G,
50 mg/ml streptomycin sulfate, 400 U/ml recombi-
nant murine IL-7 (Life Technologies, Gaithersburg,
MD), 50 U/ml recombinant murine IL-3, and 100
U/ml recombinant murine SCF (both from Immunex,
Seattle, WA). The cell suspension was plated over a
bone marrow derived stromal cell line (Collins and
Dorshkind, 1987). Cultures were fed every 5 days and
macroscopic colonies counted 10-14 days later.LYMPHOID PROGENITOR-LIKE CELLS IN A-MuLV INDUCED THYMOMAS 17
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